Literature DB >> 6883392

Specificity and basis of the tissue polypeptide antigen.

B Björklund, V Björklund.   

Abstract

TPA is an antigenic molecule which is generally present in human carcinoma tumors. Proliferating cells of tumor or normal origin produce and release TPA. Chemical characterization has shown TPA to be an unbranched peptide chain with an apparent Mr of 4.3 X 10(4) and a frictional ratio of 2.7. The electrophoretic mobility is close to that of beta 2-globulin, the IP is 4.5, and the sedimentation constant is 4.5S. The amino acid sequence of the specific determinant is known and has been synthetically produced. Antibodies to TPA obtained by affinity chromatography with BrCN-activated Sepharose, charged with isolated TPA, are responsible for reactivity with TPA by hemagglutination, radioimmunoassay, immunoelectrophoresis, immunodiffusion in gel, and immunocytochemistry. TPA is nonspecies specific and can be found down to fishes. In cell culture (HeLa) perinuclear formation of TPA is seen early in the S phase. After cell division TPA is externalized leaving the cell free of visible TPA. At this stage a rise of TPA in the cell culture medium is observed. These findings together with extensive clinical studies and use of TPA have led to the hypothesis that TPA is related to proliferative activity in general. Since cancer is based on proliferation of cells, and the genes of cancer cells are not different from those of other cells, it could be helpful to use TPA as a monitor of cell proliferation in the further search for local and general causes of proliferation. This can be done by looking for TPA in body fluids by radioimmunoassay and at the cellular level by immunocytochemistry.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6883392

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  12 in total

1.  Modified cytokeratins expressed on the surface of carcinoma cells undergo endocytosis upon binding of human monoclonal antibody and its recombinant Fab fragment.

Authors:  H J Ditzel; U Garrigues; C B Andersen; M K Larsen; H J Garrigues; A Svejgaard; I Hellström; K E Hellström; J C Jensenius
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer.

Authors:  Luis C Fernandes; Su B Kim; Sarhan S Saad; Delcio Matos
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

3.  Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation.

Authors:  T A Hembrough; K R Kralovich; L Li; S L Gonias
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

4.  Serum tissue polypeptide antigen (TPA) in thyroid cancer.

Authors:  E Martino; G Bambini; F Aghini-Lombardi; E Motz; F Pacini; R Lari; L Baschieri; A Pinchera
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

5.  Serum amylase and tissue polypeptide antigen as biochemical indicators of salivary gland injury during iodine-131 therapy.

Authors:  A Becciolini; S Porciani; A Lanini; A Benucci; A Castagnoli; A Pupi
Journal:  Eur J Nucl Med       Date:  1994-10

6.  Establishment and characterization of a cell line (OMC-9) originating from a human endometrial stromal sarcoma.

Authors:  Yoshiteru Kakuno; Takashi Yamada; Hiroshi Mori; Isamu Narabayashi
Journal:  Hum Cell       Date:  2008-05       Impact factor: 4.174

7.  Circulating cytokeratin 18 fragments and activation of dormant tumor cells in bone marrow of cancer patients.

Authors:  Christoph Ausch; Veronika Buxhofer-Ausch; Ulrike Olszewski; Gerhard Hamilton
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

8.  A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.

Authors:  P A Pasanen; M Eskelinen; K Partanen; P Pikkarainen; I Penttilä; E Alhava
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

9.  Tissue polypeptide-specific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours.

Authors:  G Kornek; T Schenk; M Raderer; M Djavarnmad; W Scheithauer
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

10.  A new human breast cancer cell line, KPL-1 secretes tumour-associated antigens and grows rapidly in female athymic nude mice.

Authors:  J Kurebayashi; M Kurosumi; H Sonoo
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.